These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception. Palazzo E, Marabese I, de Novellis V, Oliva P, Rossi F, Berrino L, Rossi F, Maione S. Neuropharmacology; 2001 Mar; 40(3):319-26. PubMed ID: 11166324 [Abstract] [Full Text] [Related]
4. Interaction between vanilloid and glutamate receptors in the central modulation of nociception. Palazzo E, de Novellis V, Marabese I, Cuomo D, Rossi F, Berrino L, Rossi F, Maione S. Eur J Pharmacol; 2002 Mar 29; 439(1-3):69-75. PubMed ID: 11937094 [Abstract] [Full Text] [Related]
6. Characterisation of mGluRs which modulate nociception in the PAG of the mouse. Maione S, Marabese I, Leyva J, Palazzo E, de Novellis V, Rossi F. Neuropharmacology; 1998 Dec 29; 37(12):1475-83. PubMed ID: 9886670 [Abstract] [Full Text] [Related]
7. Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat. de Novellis V, Mariani L, Palazzo E, Vita D, Marabese I, Scafuro M, Rossi F, Maione S. Neuroscience; 2005 Dec 29; 134(1):269-81. PubMed ID: 15953687 [Abstract] [Full Text] [Related]
8. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists. Bespalov A, Dravolina O, Belozertseva I, Adamcio B, Zvartau E. Behav Pharmacol; 2006 Jun 29; 17(4):295-302. PubMed ID: 16914947 [Abstract] [Full Text] [Related]
9. Differential roles of mGlu8 receptors in the regulation of glutamate and gamma-aminobutyric acid release at periaqueductal grey level. Marabese I, de Novellis V, Palazzo E, Mariani L, Siniscalco D, Rodella L, Rossi F, Maione S. Neuropharmacology; 2005 Jun 29; 49 Suppl 1():157-66. PubMed ID: 16084932 [Abstract] [Full Text] [Related]
13. Differential effects of NMDA and group I mGluR antagonists on both nociception and spinal cord protein kinase C translocation in the formalin test and a model of neuropathic pain in rats. Yashpal K, Fisher K, Chabot JG, Coderre TJ. Pain; 2001 Oct 29; 94(1):17-29. PubMed ID: 11576741 [Abstract] [Full Text] [Related]
15. Changes in cannabinoid receptor subtype 1 activity and interaction with metabotropic glutamate subtype 5 receptors in the periaqueductal gray-rostral ventromedial medulla pathway in a rodent neuropathic pain model. Palazzo E, Luongo L, Bellini G, Guida F, Marabese I, Boccella S, Rossi F, Maione S, de Novellis V. CNS Neurol Disord Drug Targets; 2012 Mar 29; 11(2):148-61. PubMed ID: 22483283 [Abstract] [Full Text] [Related]
16. Metabotropic glutamate receptors modulate serotonin release in the rat periaqueductal gray matter. Maione S, Palazzo E, de Novellis V, Stella L, Leyva J, Rossi F. Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct 29; 358(4):411-7. PubMed ID: 9826062 [Abstract] [Full Text] [Related]
19. N-antipyrine-3, 4-dichloromaleimide, an effective cyclic imide for the treatment of chronic pain: the role of the glutamatergic system. Quintão NL, da Silva GF, Antonialli CS, de Campos-Buzzi F, Corrêa R, Filho VC. Anesth Analg; 2010 Mar 01; 110(3):942-50. PubMed ID: 20185671 [Abstract] [Full Text] [Related]
20. The influence of AMN082, metabotropic glutamate receptor 7 (mGlu7) allosteric agonist on the acute and chronic antinociceptive effects of morphine in the tail-immersion test in mice: Comparison with mGlu5 and mGlu2/3 ligands. Gawel K, Jenda-Wojtanowska M, Gibula-Bruzda E, Kedzierska E, Filarowska J, Marszalek-Grabska M, Wojtanowski KK, Komsta L, Talarek S, Kotlinska JH. Physiol Behav; 2018 Mar 01; 185():112-120. PubMed ID: 29294304 [Abstract] [Full Text] [Related] Page: [Next] [New Search]